EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Shifting paradigms: phosphatases from basic biology to druggable targets

Catia L Pierotti iD, Marian Brenner iD, Yamini Chand iD, Fabrice Krier iD, Melina Lappe iD, Franziska Schedel iD, Malgorzata Trebacz iD

Biology Open · 15.05.2026 · 15 (5)

DOI: 10.1242/bio.062400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology Open, online erschienen am 07.05.2026. Verfasst von Catia L Pierotti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Schänzlestraße 18, 79104 Freiburg im Breisgau, Germany. Hauptthemen laut MEDLINE: Phosphoric Monoester Hydrolases, Drug Discovery, Enzyme Inhibitors. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Company of Biologists, German Research Foundation, European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The EMBO Workshop ‘Phosphatases: from basic research to translation’ (27 to 31 July 2025, Würzburg, Germany) brought together researchers from academia and industry for a deep dive into the rapidly evolving world of phosphatase biology. Over five days, participants explored the interplay of phosphatase structure, function, regulation, and signalling, while also uncovering their expanding influence in cancer, immunology, neurological disorders, and cardiometabolic health. The central focus of the meeting was the accelerating progress in phosphatase drug discovery, an enzyme class historically considered undruggable. This Meeting Review summarises the key findings and novel insights presented at the meeting and reflects the progress being made in the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphoric Monoester HydrolasesDrug DiscoveryEnzyme InhibitorsHumansSignal TransductionAnimalsMolecular Targeted Therapy

Stichwörter der Autor:innen

Basic researchCell signallingPhosphatasePhosphatase targetingTranslationWorkshop

Substanzen

Phosphoric Monoester HydrolasesEnzyme Inhibitors

Autor:innen und Institutionen

  • Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Schänzlestraße 18, 79104 Freiburg im Breisgau, Germany.
  • Institute of Biology III, Faculty of Biology, University of Freiburg, Schänzlestraße 1, 79104 Freiburg im Breisgau, Germany.
  • Institute for Cell Biology, Department of Molecular Cell Biology, University of Bonn, Käthe-Kümmel-Straße 1, 53115 Bonn, Germany.
  • Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Straße 9, 97078 Würzburg, Germany.
  • Faculty of Chemistry and Pharmacy, Hermann-Staudinger Graduate School, University of Freiburg, Hebelstraße 27, 79087 Freiburg im Breisgau, Germany.
  • Spemann Graduate School of Biology and Medicine, University of Freiburg, Albertstraße 19A, 79104 Freiburg im Breisgau, Germany.

ORCID-Profile: Catia L Pierotti, Marian Brenner, Yamini Chand, Fabrice Krier, Melina Lappe, Franziska Schedel, Malgorzata Trebacz

Förderung

  • Company of Biologists
  • German Research Foundation
  • European Research Council
  • Studienstiftung des deutschen Volkes
  • The Company of Biologists, Scientific Meeting Grant
  • EMBO79

Zitieren

APA

Pierotti, C. L., Brenner, M., Chand, Y., Krier, F., Lappe, M., Schedel, F., & Trebacz, M. (2026). Shifting paradigms: phosphatases from basic biology to druggable targets. Biology Open, 15(5). https://doi.org/10.1242/bio.062400

Vancouver

Pierotti CL, Brenner M, Chand Y, Krier F, Lappe M, Schedel F, et al. Shifting paradigms: phosphatases from basic biology to druggable targets. Biology Open. 2026;15(5). doi:10.1242/bio.062400

BibTeX
@article{Pierotti2026,
  author = {Pierotti, Catia L and Brenner, Marian and Chand, Yamini and Krier, Fabrice and Lappe, Melina and Schedel, Franziska and Trebacz, Malgorzata},
  title = {Shifting paradigms: phosphatases from basic biology to druggable targets},
  journal = {Biology Open},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.1242/bio.062400}
}
Kostenlos starten →